DNA stabilization is critical for maximizing performance of fecal DNA-based colorectal cancer tests

Diagnostic Molecular Pathology

Volumn 14, Issue 3, 2005, Pages 183-191

  Olson, Jeff ^a   Whitney, Duncan H ^a   Durkee, Kristine ^a   Shuber, Anthony P ^a  

^a Exact Sciences Corporation   (United States)

Author keywords

Cancer screening; Colorectal cancer; DNA integrity; Multitarget assay; Stool DNA

Indexed keywords

DNA BASE; DNA FRAGMENT;

ARTICLE; CANCER SCREENING; CANCER TEST; CLINICAL ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; DNA DEGRADATION; DNA DETERMINATION; DNA INTEGRATION; DNA SCREENING; FECES ANALYSIS; GENE MUTATION; HUMAN; POINT MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; ROOM TEMPERATURE;

BUFFERS; COLORECTAL NEOPLASMS; DNA, NEOPLASM; FECES; HUMANS; MOLECULAR DIAGNOSTIC TECHNIQUES; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SPECIMEN HANDLING;

EID: 25844481536     PISSN: 10529551     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.pas.0000176768.18423.7e     Document Type: Article

References (31)

1. Weir HK, Thun MJ, Hankey BF, et al. Annual report to the nation on the status of cancer, 1975-2000, Featuring the uses of surveillance data for cancer prevention and -control. J Natl Cancer Inst. 2003;95:1276-1299.
2. Toribara NW, Sleisenger MH. Screening for colorectal cancer. N Engl J Med. 1995;332:861-867.
3. Smith RA, Cokkinides V, Eyre HJ. American Cancer Society Guidelines for the detection of cancer. CA Cancer J Clin. 2004;54:41-52.
4. Winawer S, Fletcher R, Rex D, et al. Colorectal cancer screening and surveillance: Clinical guidelines and rationale-Update based on new evidence. Gastroenterology. 2003;124:544-560.
5. U.S Preventative Services Task Force. Screening for colorectal cancer: recommendation and rationale. Ann Intern Med. 2002;137:129.
6. Ahlquist DA, Skoletsky JE, Boynton KA, et al. Colorectal cancer screening by detection of altered human DNA in stool: Feasibility of a multi-target assay panel. Gastroenterology. 2000;119:1219-1227.
7. Brand RE, Ross ME, Shuber AP. Reproducibility of a multi-target stool-based assay for colorectal cancer detection. Am J Gastroenterol. 2004;99:1338-1341.
8. Tagore KS, Lawson MJ, Yucaitis JA, et al. Sensitivity and specificity of a stool DNA multi-target assay panel for the detection of advanced colorectal neoplasia. Clin Colorectal Cancer. 2003;3:47-53.
9. Imperiale TF, Ransohoff DF, Itzkowitz SH, et al. Fecal DNA versus fecal occult blood for colorectal cancer screening in an average risk population. N Engl J Med. 2004;351:2704-2714.
10. Whitney D, Skoletsky J, Moore K, et al. Enhanced retrieval of DNA from human fecal samples results in improved performance of colorectal cancer screening assay. J Mol Diagn. 2004;6:386-395.
11. Boynton KA, Summerhayes IC, Ahlquist DA, et al. DNA integrity as a potential marker for stool-based detection of colorectal cancer. Clin Chem. 2003;49:1058-1065.
12. Sidransky D, Tokino T, Hamilton SR, et al. Identification of ras oncogene mutations in the stool of patients with curable colorectal tumors. Science. 1992;256:102-105.
13. Villa E, Dugani A, Rebecchi AM, et al. Idendification of subjects at risk for colorectal carcinoma through a test based on K-ras determination in the stool. Gastroenterology. 1996;110:1346-1353.
14. Nollau P, Moser C, Weinland G, et al. Detection of K-ras mutations in stools of patients with colorectal cancer by mutant-enriched PCR. Int J Cancer. 1996;66:332-336.
15. Eguchi S, Kohara N, Komuta K, et al. Mutations of the p53 gene in the stool of patients with resectable colorectal cancer. Cancer. 1996;77(8 Suppl):1707-1710.
16. Lev Z, Kislitsin D, Rennert G, et al. Utilization of K-ras mutations identified in stool DNA for the early detection of colorectal cancer. J Cell Biochem Suppl. 2000;34:35-39.
17. Deuter R, Muller O. Detection of APC mutations in stool DNA of patients with colorectal cancer by HD-PCR. Hum Mutat. 1998;11:84-89.
18. Dong S, Traverso G, Johnson C, et al. Detecting colorectal cancer in stool with the use of multiple genetic targets. J Natl Cancer Inst. 2001;93:858-865.
19. Rengucci C, Maiolo P, Saragoni L, et al. Multiple detection of genetic alterations in tumors and stool. Clin Cancer Res. 2001;7:590-593.
20. Ahlquist DA, Harrington JJ, Burgart LJ, et al. Morphometric analysis of the "mucocellular layer" overlying colorectal cancer and normal mucosa: Relevance to exfoliation and stool screening. Hum Pathol. 2000;31:51-57.
21. Loktionov A, O'Neill IK, Silvester KR, et al. Quantitation of DNA from exfoliated colonocytes isolated from human stool surface as a novel noninvasive screening test for colorectal cancer. Clin Cancer Res. 1999;4:337-342.
22. Klaassenl CHW, Jeuninkl MAF, Prinsenl CFM, et al. Quantification of human DNA in feces as a diagnostic test for the presence of colorectal cancer. Clin Chem. 2003;49:1185-1187.
23. Johnson PJ, Lo YMD. Plasma nucleic acids in the diagnosis and management of malignant disease. Clin Chem. 2002;48:1186-1193.
24. Anker P, Mulcahy H, Chen XQ, et al. Detection of circulating tumor DNA in the blood (plasma/serum) of cancer patients. Cancer Metastasis Rev. 1999;18:65-73.
25. Chang HW, Lee SM, Goodman SN, et al. Assessment of plasma DNA levels, allelic imbalance, and CA 125 as diagnostic tests for cancer. J Natl Cancer Inst. 2002;94:1697-1703.
26. Jahr S, Hentze H, Englisch S, et al. DNA fragments in the blood plasma of cancer patients: Quantitations and evidence for their origin from apoptotic and necrotic cells. Cancer Res. 2001;61:1659-1665.
27. Taback B, O'Day SJ, Hoon DS. Quantification of circulating DNA in the plasma and serum of cancer patients. Ann N Y Acad Sci. 2004;1022:17-24.
28. Wang BG, Huang HY, Chen YC, et al. Increased plasma DNA integrity in cancer patients. Cancer Res. 2003;63:3966-3968.
29. Chan AKC, Yeung S-W, Lui W-B, et al. Effects of preanalytical factors on the molecular size of cell-free DNA in blood. Clin Chem. 2005;4:781-783.
30. Vogelstein B, Kinzler KW. Digital PCR. Proc Natl Acad Sci U S A. 1999;96:9236-9241.
31. Pohl G, Shih L-M. Principle and applications of digital PCR. Expert Rev Mol Diagn. 2004;4:41-47.